Imidazole-Based AT₁ Receptor Ligands: Design, Synthesis and Pharmacological Evaluation

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Cardiovascular Research

Background:

• The renin-angiotensin system (RAS) plays a crucial role in cardiovascular and renal homeostasis.
• Angiotensin II type 1 (AT1) receptors are validated therapeutic targets for related disorders.
• Selective modulation of AT1 versus AT2 receptors is vital for drug development and mechanistic studies.

Purpose of the Study:

• To synthesize and evaluate novel imidazole-based compounds for their binding affinities to AT1 and AT2 receptors.
• To establish structure-activity relationships (SAR) for these compounds.
• To identify potent and selective AT1 receptor modulators.

Main Methods:

• Synthesis of a novel series of imidazole-based compounds.
• Radioligand binding assays using [3H]-angiotensin II to determine affinities for AT1 and AT2 receptors.
• Molecular docking studies utilizing the AT1 receptor crystal structure (PDB: 8TH4).

Main Results:

• Sulfonamide substitution significantly enhanced AT1 receptor affinity.
• Sterically hindered and ester-containing derivatives showed reduced activity.
• The most potent compound exhibited high AT1 affinity (Ki = 5 nM), comparable to losartan.
• All synthesized compounds demonstrated preferential binding for AT1 over AT2 receptors.

Conclusions:

• Novel imidazole-based compounds were successfully synthesized and characterized.
• SAR analysis identified key structural features for AT1 receptor affinity.
• These compounds represent promising candidates for further investigation as AT1 receptor modulators in cardiovascular and renal diseases.